190 related articles for article (PubMed ID: 25806852)
1. Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
Wong HK; Gibson H; Hake T; Geyer S; Frederickson J; Marcucci G; Caligiuri MA; Porcu P; Mishra A
J Invest Dermatol; 2015 Aug; 135(8):2084-2092. PubMed ID: 25806852
[TBL] [Abstract][Full Text] [Related]
2. Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma.
Jones CL; Ferreira S; McKenzie RC; Tosi I; Caesar JA; Bagot M; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2012 Aug; 132(8):2042-9. PubMed ID: 22495182
[TBL] [Abstract][Full Text] [Related]
3. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP
Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612
[TBL] [Abstract][Full Text] [Related]
4. Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma.
Bégué E; Jean-Louis F; Bagot M; Jauliac S; Cayuela JM; Laroche L; Parquet N; Bachelez H; Bensussan A; Courtois G; Michel L
Blood; 2012 Jul; 120(1):143-54. PubMed ID: 22627769
[TBL] [Abstract][Full Text] [Related]
5. Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis.
Michel L; Jean-Louis F; Begue E; Bensussan A; Bagot M
Blood; 2013 Feb; 121(8):1477-8. PubMed ID: 23429988
[No Abstract] [Full Text] [Related]
6. Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.
Boonk SE; Zoutman WH; Putter H; Ram-Wolff C; Felcht M; Klemke CD; Ranki A; Quaglino P; Whittaker S; Bagot M; Willemze R; Vermeer MH
J Invest Dermatol; 2017 Mar; 137(3):754-757. PubMed ID: 27984038
[No Abstract] [Full Text] [Related]
7. Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation.
Jones CL; Wain EM; Chu CC; Tosi I; Foster R; McKenzie RC; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2010 Apr; 130(4):1116-25. PubMed ID: 19759548
[TBL] [Abstract][Full Text] [Related]
8. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.
Kamijo H; Miyagaki T; Shishido-Takahashi N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
Blood; 2018 Nov; 132(18):1922-1935. PubMed ID: 30194255
[TBL] [Abstract][Full Text] [Related]
9. Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.
Sung CO; Lee KW; Han S; Kim SH
Am J Pathol; 2011 Oct; 179(4):1827-38. PubMed ID: 21854747
[TBL] [Abstract][Full Text] [Related]
10. TWIST1 upregulates the MAGEA4 oncogene.
Forghanifard MM; Rad A; Farshchian M; Khaleghizadeh M; Gholamin M; Moghbeli M; Abbaszadegan MR
Mol Carcinog; 2017 Mar; 56(3):877-885. PubMed ID: 27533647
[TBL] [Abstract][Full Text] [Related]
11. Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A.
Cao L; Wang S; Zhang Y; Wong KC; Nakatsu G; Wang X; Wong S; Ji J; Yu J
Oncogene; 2018 Jun; 37(26):3601-3616. PubMed ID: 29610526
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells.
Iżykowska K; Rassek K; Żurawek M; Nowicka K; Paczkowska J; Ziółkowska-Suchanek I; Podralska M; Dzikiewicz-Krawczyk A; Joks M; Olek-Hrab K; Giefing M; Przybylski GK
J Cell Mol Med; 2020 Sep; 24(18):10970-10977. PubMed ID: 32794659
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells.
Sakamoto A; Akiyama Y; Shimada S; Zhu WG; Yuasa Y; Tanaka S
PLoS One; 2015; 10(12):e0145630. PubMed ID: 26695186
[TBL] [Abstract][Full Text] [Related]
14. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
[TBL] [Abstract][Full Text] [Related]
16. Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers.
van Doorn R; Slieker RC; Boonk SE; Zoutman WH; Goeman JJ; Bagot M; Michel L; Tensen CP; Willemze R; Heijmans BT; Vermeer MH
J Invest Dermatol; 2016 Sep; 136(9):1876-1884. PubMed ID: 27113428
[TBL] [Abstract][Full Text] [Related]
17. SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically.
Wang Z; Zhang J; Zhang Y; Lim SH
Int J Cancer; 2006 Mar; 118(6):1436-44. PubMed ID: 16187275
[TBL] [Abstract][Full Text] [Related]
18. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
19. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer.
Gort EH; Suijkerbuijk KP; Roothaan SM; Raman V; Vooijs M; van der Wall E; van Diest PJ
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3325-30. PubMed ID: 19064546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
